{"id":"NCT02963766","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes","officialTitle":"A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-12-29","primaryCompletion":"2021-06-12","completion":"2022-01-12","firstPosted":"2016-11-15","resultsPosted":"2022-07-01","lastUpdate":"2022-07-01"},"enrollment":154,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"Dulaglutide","otherNames":["LY2189265"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo/0.75 milligram (mg) Dulaglutide","type":"EXPERIMENTAL"},{"label":"0.75 mg Dulaglutide","type":"EXPERIMENTAL"},{"label":"1.5 mg Dulaglutide","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics and pharmacodynamics of the study drug dulaglutide compared to placebo in pediatric participants with type 2 diabetes. The study duration is approximately 60 weeks.","primaryOutcome":{"measure":"Change From Baseline in Hemoglobin A1c (HbA1c) (Pooled Doses) at Week 26","timeFrame":"Baseline, Week 26","effectByArm":[{"arm":"Placebo","deltaMin":0.5,"sd":0.24},{"arm":"Pooled Dulaglutide","deltaMin":-0.7,"sd":0.16}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"10 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":12},"locations":{"siteCount":61,"countries":["United States","Brazil","France","Germany","Hungary","India","Mexico","Puerto Rico","Saudi Arabia","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["39963952","35658022"],"seeAlso":["https://trials.lillytrialguide.com/en-US/trial/5RwyJT8t9uI0ISG4U4SEu0"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":51},"commonTop":["Diarrhoea","Headache","Vomiting","Nausea","Abdominal pain upper"]}}